Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-04 4:00 pm Purchase |
2025-04-01 | 13G | 10x Genomics, Inc. TXG |
MILLENNIUM MANAGEMENT LLC | 5,533,618 5.100% |
5,533,618 (New Position) |
Filing History |
| 2024-11-08 2:46 pm Purchase |
2024-09-30 | 13G | 10x Genomics, Inc. TXG |
Nikko Asset Management Americas, Inc. | 6,373,212 5.980% |
6,373,212 (New Position) |
Filing History |
| 2024-11-05 06:07 am Purchase |
2024-09-30 | 13G | 10x Genomics, Inc. TXG |
Sumitomo Mitsui Trust Group, Inc. | 6,373,212 5.980% |
6,373,212 (New Position) |
Filing History |
| 2024-10-04 2:14 pm Purchase |
2024-09-30 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 10,972,930 10.300% |
1,961,598 (+21.77%) |
Filing History |
| 2024-08-12 11:16 am Purchase |
2024-07-31 | 13G | 10x Genomics, Inc. TXG |
ARK Investment Management LLC | 11,357,011 10.750% |
11,357,011 (New Position) |
Filing History |
| 2024-06-07 09:55 am Sale |
2024-05-31 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 2,777,115 2.630% |
-5,142,861 (-64.94%) |
Filing History |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 9,011,332 8.650% |
591,321 (+7.02%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 17,731,269 16.252% |
4,683,939 (+35.90%) |
Filing History |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | 10x Genomics, Inc. TXG |
BLACKROCK INC BLK |
5,705,051 5.500% |
385,872 (+7.25%) |
Filing History |
| 2024-01-29 11:43 am Sale |
2023-12-29 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 7,919,976 7.600% |
-682,259 (-7.93%) |
Filing History |
| 2023-12-08 4:37 pm Sale |
2023-11-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
3,630,398 3.500% |
-1,509,063 (-29.36%) |
Filing History |
| 2023-07-10 4:38 pm Sale |
2023-06-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
5,139,461 5.200% |
-4,755,518 (-48.06%) |
Filing History |
| 2023-07-10 10:20 am Purchase |
2023-07-07 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 13,047,330 12.658% |
4,154,232 (+46.71%) |
Filing History |
| 2023-02-14 4:05 pm Unchanged |
2022-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 4,828,247 4.900% |
0 (Unchanged) |
Filing History |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 8,420,011 8.810% |
865,969 (+11.46%) |
Filing History |
| 2023-02-09 08:14 am Sale |
2023-02-09 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 8,893,098 8.780% |
-4,385,709 (-33.03%) |
Filing History |
| 2023-02-08 11:17 am Sale |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
9,894,979 10.400% |
-446,774 (-4.32%) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | 10x Genomics, Inc. TXG |
BLACKROCK INC BLK |
5,319,179 5.600% |
327,892 (+6.57%) |
Filing History |
| 2023-01-18 06:24 am Purchase |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 8,602,235 9.000% |
1,723,858 (+25.06%) |
Filing History |
| 2022-09-12 4:29 pm Purchase |
2022-08-31 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
10,341,753 10.900% |
5,732,995 (+124.39%) |
Filing History |